Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
July-2025 Volume 32 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2025 Volume 32 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data1.pdf
    • Supplementary_Data2.pdf
Article Open Access

Eburicoic acid inhibits endothelial cell pyroptosis and retards the development of atherosclerosis through the Keap1/Nrf2/HO‑1/ROS pathway

  • Authors:
    • Meng-Qing Ma
    • Chun Yang
    • Shi-Yu Jin
    • Yu Yang
    • Yan-Yan Pan
    • Xian-He Lin
  • View Affiliations / Copyright

    Affiliations: Department of Cardiology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, P.R. China, Department of Cardiology, Hefei Cancer Hospital, Chinese Academy of Sciences, Hefei, Anhui 230022, P.R. China
    Copyright: © Ma et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 186
    |
    Published online on: May 2, 2025
       https://doi.org/10.3892/mmr.2025.13551
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Atherosclerosis (AS)‑related coronary artery disease is the main cause of morbidity and mortality around the globe. Eburicoic acid, a triterpenoid compound from Antrodia camphorata, exerts anti‑inflammatory and anti‑hyperlipidemic effects, although its role in atherogenesis remains unknown. Endothelial cell pyroptosis‑caused chronic inflammatory response within vessel walls is a critical initial event in atherogenesis, making it a promising target to prevent AS. The present study was designed to investigate the effects of eburicoic acid on endothelial cell pyroptosis, AS progression and the underlying mechanisms. The results showed that with dose and time increased, treatment of human umbilical vascular endothelial cells (HUVECs) with eburicoic acid markedly decreased the expression of Kelch‑like ECH‑associated protein 1 (Keap1), NF‑E2‑related factor 2 (Nrf2), reactive oxygen species (ROS), NLR family pyrin domain‑containing protein 3 (NLRP3), cleaved caspase‑1, apoptosis‑associated speck‑like protein containing CARD (ASC), N‑terminal gasdermin‑D (GSDMD‑N), downregulated the secretion levels of pro‑inflammatory cytokines interleukin (IL) 1β, IL‑6 and IL‑18, inhibited caspase‑1 activity and lactate dehydrogenase release and improved plasma membrane integrity. By contrast, the expression of nuclear Nrf2, total Nrf2 and heme oxygenase‑1 (HO‑1) were increased by eburicoic acid treatment in HUVECs dose‑ and time‑dependently. Moreover, the inhibitory effects of eburicoic acid on HUVEC pyroptosis were mainly compromised by pre‑treatment with ROS agonist, HO‑1 small interfering (si)RNA, or Nrf2 siRNA. Finally, it was observed that administering high‑fat‑diet fed ApoE‑/‑ mice with eburicoic acid markedly increased Nrf2 and HO‑1 levels and reduced the expression of Keap1, NLRP3, cleaved caspase‑1, ASC and GSDMD‑N in aortas and ameliorated hyperlipidemia and inflammation in the serum, leading to smaller atherosclerotic plaques, less lipid accumulation and high content of collagen fiber within plaques. These findings identified eburicoic acid as a potent anti‑atherogenic natural product by suppressing endothelial cell pyroptosis via the Keap1/Nrf2/HO‑1/ROS pathway. Eburicoic acid may be considered an effective phytomedicine for treating AS.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Dibben GO, Faulkner J, Oldridge N, Rees K, Thompson DR, Zwisler AD and Taylor RS: Exercise-based cardiac rehabilitation for coronary heart disease: A meta-analysis. Eur Heart J. 44:452–469. 2023. View Article : Google Scholar : PubMed/NCBI

2 

Pan H, Ho SE, Xue C, Cui J, Johanson QS, Sachs N, Ross LS, Li F, Solomon RA, Connolly ES Jr, et al: Atherosclerosis is a smooth muscle Cell-Driven Tumor-like disease. Circulation. 149:1885–1898. 2024. View Article : Google Scholar : PubMed/NCBI

3 

Xing Y and Lin X: Challenges and advances in the management of inflammation in atherosclerosis. J Adv Res. Jun 21–2024.doi: 10.1016/j.jare.2024.06.016.

4 

Jia M, Li Q, Guo J, Shi W, Zhu L, Huang Y, Li Y, Wang L, Ma S, Zhuang T, et al: Deletion of BACH1 attenuates atherosclerosis by reducing endothelial inflammation. Circ Res. 130:1038–1055. 2022. View Article : Google Scholar : PubMed/NCBI

5 

Wang Q, Han J, Liang Z, Geng X, Du Y, Zhou J, Yao W and Xu T: FSH is responsible for androgen deprivation Therapy-associated atherosclerosis in mice by exaggerating endothelial inflammation and monocyte adhesion. Arterioscler Thromb Vasc Biol. 44:698–719. 2024. View Article : Google Scholar : PubMed/NCBI

6 

Oladapo A, Jackson T, Menolascino J and Periyasamy P: Role of pyroptosis in the pathogenesis of various neurological diseases. Brain Behav Immun. 117:428–446. 2024. View Article : Google Scholar : PubMed/NCBI

7 

Volchuk A, Ye A, Chi L, Steinberg BE and Goldenberg NM: Indirect regulation of HMGB1 release by gasdermin D. Nat Commun. 11:45612020. View Article : Google Scholar : PubMed/NCBI

8 

Gimbrone MA Jr and García-Cardeña G: Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ Res. 118:620–636. 2016. View Article : Google Scholar : PubMed/NCBI

9 

Yin Y, Li X, Sha X, Xi H, Li YF, Shao Y, Mai J, Virtue A, Lopez-Pastrana J, Meng S, et al: Early hyperlipidemia promotes endothelial activation via a caspase-1-sirtuin 1 pathway. Arterioscler Thromb Vasc Biol. 35:804–816. 2015. View Article : Google Scholar : PubMed/NCBI

10 

Lv Y, Jiang Z, Zhou W, Yang H, Jin G, Wang D, Kong C, Qian Z, Gu Y, Chen S and Zhu L: Low-shear stress promotes atherosclerosis via inducing endothelial cell pyroptosis mediated by IKKε/STAT1/NLRP3 pathway. Inflammation. 47:1053–1066. 2024. View Article : Google Scholar : PubMed/NCBI

11 

Chen Y, Yuan C, Qin W, Yu B, Wei D and Wu P: TMAO promotes vascular endothelial cell pyroptosis via the LPEAT-mitophagy pathway. Biochem Biophys Res Commun. 703:1496672024. View Article : Google Scholar : PubMed/NCBI

12 

Song L, Zhang J, Lai R, Li Q, Ju J and Xu H: Chinese herbal medicines and active metabolites: Potential antioxidant treatments for atherosclerosis. Front Pharmacol. 12:6759992021. View Article : Google Scholar : PubMed/NCBI

13 

Jing Y, Hu T, Yuan J, Liu Z, Tao M, Ou M, Cheng X, Cheng W, Yi Y and Xiong Q: Resveratrol protects against postmenopausal atherosclerosis progression through reducing PCSK9 expression via the regulation of the ERα-mediated signaling pathway. Biochem Pharmacol. 211:1155412023. View Article : Google Scholar : PubMed/NCBI

14 

Gao S, Zhang W, Zhao Q, Zhou J, Wu Y, Liu Y, Yuan Z and Wang L: Curcumin ameliorates atherosclerosis in apolipoprotein E deficient asthmatic mice by regulating the balance of Th2/Treg cells. Phytomedicine. 52:129–135. 2019. View Article : Google Scholar : PubMed/NCBI

15 

Xing SS, Yang J, Li WJ, Li J, Chen L, Yang YT, Lei X, Li J, Wang K and Liu X: Salidroside decreases atherosclerosis plaque formation via inhibiting endothelial cell pyroptosis. Inflammation. 43:433–440. 2020. View Article : Google Scholar : PubMed/NCBI

16 

Cao H, Jia Q, Yan L, Chen C, Xing S and Shen D: Quercetin suppresses the progression of atherosclerosis by regulating MST1-Mediated autophagy in ox-LDL-Induced RAW264.7 macrophage foam cells. Int J Mol Sci. 20:60932019. View Article : Google Scholar : PubMed/NCBI

17 

Ma SR, Tong Q, Lin Y, Pan LB, Fu J, Peng R, Zhang XF, Zhao ZX, Li Y, Yu JB, et al: Berberine treats atherosclerosis via a vitamine-like effect down-regulating Choline-TMA-TMAO production pathway in gut microbiota. Signal Transduct Target Ther. 7:2072022. View Article : Google Scholar : PubMed/NCBI

18 

Deng JS, Huang SS, Lin TH, Lee MM, Kuo CC, Sung PJ, Hou WC, Huang GJ and Kuo YH: Analgesic and anti-inflammatory bioactivities of eburicoic acid and dehydroeburicoic acid isolated from Antrodia camphorata on the inflammatory mediator expression in mice. J Agric Food Chem. 61:5064–5071. 2013. View Article : Google Scholar : PubMed/NCBI

19 

Tung YT, Tsai TC, Kuo YH, Yen CC, Sun JY, Chang WH, Chen HL and Chen CM: Comparison of solid-state-cultured and wood-cultured Antrodia camphorata in anti-inflammatory effects using NF-κB/luciferase inducible transgenic mice. Phytomedicine. 21:1708–1716. 2014. View Article : Google Scholar : PubMed/NCBI

20 

Su YC, Liu CT, Chu YL, Raghu R, Kuo YH and Sheen LY: Eburicoic acid, an active triterpenoid from the fruiting bodies of basswood cultivated antrodia cinnamomea, induces ER Stress-mediated autophagy in human hepatoma cells. J Tradit Complement Med. 2:312–322. 2012. View Article : Google Scholar : PubMed/NCBI

21 

Huang GJ, Deng JS, Huang SS, Lee CY, Hou WC, Wang SY, Sung PJ and Kuo YH: Hepatoprotective effects of eburicoic acid and dehydroeburicoic acid from Antrodia camphorata in a mouse model of acute hepatic injury. Food Chem. 141:3020–3027. 2013. View Article : Google Scholar : PubMed/NCBI

22 

Wang J, Zhang P, He H, Se X, Sun W, Chen B, Zhang L, Yan X and Zou K: Eburicoic acid from Laetiporus sulphureus (Bull.:Fr.) Murrill attenuates inflammatory responses through inhibiting LPS-induced activation of PI3K/Akt/mTOR/NF-κB pathways in RAW264.7 cells. Naunyn Schmiedebergs Arch Pharmacol. 390:845–856. 2017. View Article : Google Scholar : PubMed/NCBI

23 

Lin CH, Kuo YH and Shih CC: Eburicoic acid, a triterpenoid compound from Antrodia camphorata, displays antidiabetic and antihyperlipidemic effects in Palmitate-treated C2C12 myotubes and in High-Fat Diet-Fed mice. Int J Mol Sci. 18:23142017. View Article : Google Scholar : PubMed/NCBI

24 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

25 

Andrews CS, Matsuyama S, Lee BC and Li JD: Resveratrol suppresses NTHi-induced inflammation via up-regulation of the negative regulator MyD88 short. Sci Rep. 6:344452016. View Article : Google Scholar : PubMed/NCBI

26 

Jiang X, Ma C, Gao Y, Zheng Y, Li J, Zong W and Zhang Q: Tongxinluo attenuates atherosclerosis by inhibiting ROS/NLRP3/caspase-1-mediated endothelial cell pyroptosis. J Ethnopharmacol. 304:1160112023. View Article : Google Scholar : PubMed/NCBI

27 

Zhou Y, Zhang Y, Wang H, Zhang X, Chen Y and Chen G: Microglial pyroptosis in hippocampus mediates Sevolfurane-induced cognitive impairment in aged mice via ROS-NLRP3 inflammasome pathway. Int Immunopharmacol. 116:1097252023. View Article : Google Scholar : PubMed/NCBI

28 

Luo P, Liu D, Zhang Q, Yang F, Wong YK, Xia F, Zhang J, Chen J, Tian Y, Yang C, et al: Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1. Acta Pharm Sin B. 12:2300–2314. 2022. View Article : Google Scholar : PubMed/NCBI

29 

Yang W, Wang Y, Zhang C, Huang Y, Yu J, Shi L, Zhang P, Yin Y, Li R and Tao K: Maresin1 protect against ferroptosis-induced liver injury through ROS inhibition and Nrf2/HO-1/GPX4 activation. Front Pharmacol. 13:8656892022. View Article : Google Scholar : PubMed/NCBI

30 

Hong H, Lou S, Zheng F, Gao H, Wang N, Tian S, Huang G and Zhao H: Hydnocarpin D attenuates lipopolysaccharide-induced acute lung injury via MAPK/NF-κB and Keap1/Nrf2/HO-1 pathway. Phytomedicine. 101:1541432022. View Article : Google Scholar : PubMed/NCBI

31 

Chen H, Fu J, Chen H, Hu Y, Soroka DN, Prigge JR, Schmidt EE, Yan F, Major MB, Chen X and Sang S: Ginger compound [6]-shogaol and its cysteine-conjugated metabolite (M2) activate Nrf2 in colon epithelial cells in vitro and in vivo. Chem Res Toxicol. 27:1575–1585. 2014. View Article : Google Scholar : PubMed/NCBI

32 

Luo RR, Yang J, Sun YL, Zhou BY, Zhou SX, Zhang GX and Yang AX: Dexmedetomidine attenuates ferroptosis by Keap1-Nrf2/HO-1 pathway in LPS-induced acute kidney injury. Naunyn Schmiedebergs Arch Pharmacol. 397:7785–7796. 2024. View Article : Google Scholar : PubMed/NCBI

33 

Yan Q, Li P, Liu S, Sun Y, Chen C, Long J, Lin Y, Liang J, Wang H, Zhang L, et al: Dihydromyricetin treats pulmonary hypertension by modulating CKLF1/CCR5 axis-induced pulmonary vascular cell pyroptosis. Biomed Pharmacother. 180:1176142024. View Article : Google Scholar : PubMed/NCBI

34 

Wang Y, Guan X, Gao CL, Ruan W, Zhao S, Kai G, Li F and Pang T: Medioresinol as a novel PGC-1α activator prevents pyroptosis of endothelial cells in ischemic stroke through PPARα-GOT1 axis. Pharmacol Res. 169:1056402021. View Article : Google Scholar : PubMed/NCBI

35 

Zhu J, Chen H, Le Y, Guo J, Liu Z, Dou X and Lu D: Salvianolic acid A regulates pyroptosis of endothelial cells via directly targeting PKM2 and ameliorates diabetic atherosclerosis. Front Pharmacol. 13:10092292022. View Article : Google Scholar : PubMed/NCBI

36 

He J, Deng Y, Ren L, Jin Z, Yang J, Yao F, Liu Y, Zheng Z, Chen D, Wang B, et al: Isoliquiritigenin from licorice flavonoids attenuates NLRP3-mediated pyroptosis by SIRT6 in vascular endothelial cells. J Ethnopharmacol. 303:1159522023. View Article : Google Scholar : PubMed/NCBI

37 

Liu M, Luo G, Liu T, Yang T, Wang R, Ren W, Liu P, Lai X, Zhou H and Yang S: Zhilong huoxue tongyu capsule alleviated the pyroptosis of vascular endothelial cells induced by ox-LDL through miR-30b-5p/NLRP3. Evid Based Complement Alternat Med. 2022:39813502022.PubMed/NCBI

38 

Tan C, Chen J, Tu T, Chen L and Zou J: Lycopene inhibits pyroptosis of endothelial progenitor cells induced by ox-LDL through the AMPK/mTOR/NLRP3 pathway. Open Med (Wars). 19:202409732024. View Article : Google Scholar : PubMed/NCBI

39 

Saba E, Son Y, Jeon BR, Kim SE, Lee IK, Yun BS and Rhee MH: Acetyl eburicoic acid from laetiporus sulphureus var. miniatus suppresses inflammation in murine macrophage RAW 264.7 cells. Mycobiology. 43:131–136. 2015. View Article : Google Scholar : PubMed/NCBI

40 

Wang J, Sun W, Luo H, He H, Deng W, Zou K, Liu C, Song J and Huang W: Protective effect of eburicoic acid of the chicken of the woods mushroom, laetiporus sulphureus (Higher Basidiomycetes), against gastric ulcers in mice. Int J Med Mushrooms. 17:619–626. 2015. View Article : Google Scholar : PubMed/NCBI

41 

Lin CH, Kuo YH and Shih CC: Antidiabetic and hypolipidemic activities of eburicoic acid, a triterpenoid compound from Antrodia camphorata, by regulation of Akt phosphorylation, gluconeogenesis, and PPARα in streptozotocin-induced diabetic mice. RSC Adv. 8:20462–20476. 2018. View Article : Google Scholar : PubMed/NCBI

42 

La Chica Lhoëst MT, Martinez A, Claudi L, Garcia E, Benitez-Amaro A, Polishchuk A, Piñero J, Vilades D, Guerra JM, Sanz F, et al: Mechanisms modulating foam cell formation in the arterial intima: Exploring new therapeutic opportunities in atherosclerosis. Front Cardiovasc Med. 11:13815202024. View Article : Google Scholar : PubMed/NCBI

43 

Jin Y, Liu Y, Xu L, Xiong Y, Peng Y, Ding K, Zheng S, Yang N, Zhang Z, Li L, et al: Novel role for caspase 1 inhibitor VX765 in suppressing NLRP3 inflammasome assembly and atherosclerosis via promoting mitophagy and efferocytosis. Cell Death Dis. 13:5122022. View Article : Google Scholar : PubMed/NCBI

44 

Zhang Q, Liu J, Duan H, Li R, Peng W and Wu C: Activation of Nrf2/HO-1 signaling: An important molecular mechanism of herbal medicine in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stress. J Adv Res. 34:43–63. 2021. View Article : Google Scholar : PubMed/NCBI

45 

Hu Q, Zhang T, Yi L, Zhou X and Mi M: Dihydromyricetin inhibits NLRP3 inflammasome-dependent pyroptosis by activating the Nrf2 signaling pathway in vascular endothelial cells. Biofactors. 44:123–136. 2018. View Article : Google Scholar : PubMed/NCBI

46 

Lee SE, Jeong SI, Yang H, Park CS, Jin YH and Park YS: Fisetin induces Nrf2-mediated HO-1 expression through PKC-δ and p38 in human umbilical vein endothelial cells. J Cell Biochem. 112:2352–2360. 2011. View Article : Google Scholar : PubMed/NCBI

47 

Zhu Z, Li J and Zhang X: Astragaloside IV protects against oxidized Low-density lipoprotein (ox-LDL)-induced endothelial cell injury by reducing oxidative stress and inflammation. Med Sci Monit. 25:2132–2140. 2019. View Article : Google Scholar : PubMed/NCBI

48 

Li CP, Qin G, Shi RZ, Zhang MS and Lv JY: Ginsenoside Rg1 reduces toxicity of PM(2.5) on human umbilical vein endothelial cells by upregulating intracellular antioxidative state. Environ Toxicol Pharmacol. 35:21–29. 2013. View Article : Google Scholar : PubMed/NCBI

49 

Lu CY, Yang YC, Li CC, Liu KL, Lii CK and Chen HW: Andrographolide inhibits TNFα-induced ICAM-1 expression via suppression of NADPH oxidase activation and induction of HO-1 and GCLM expression through the PI3K/Akt/Nrf2 and PI3K/Akt/AP-1 pathways in human endothelial cells. Biochemical Pharmacology. 91:40–50. 2014. View Article : Google Scholar : PubMed/NCBI

50 

Kong C, Yan X, Zhu Y, Zhu H, Luo Y, Liu P, Ferrandon S, Kalady MF, Gao R, He J, et al: Fusobacterium nucleatum promotes the development of colorectal cancer by activating a cytochrome P450/Epoxyoctadecenoic acid axis via TLR4/Keap1/NRF2 signaling. Cancer Res. 81:4485–4498. 2021. View Article : Google Scholar : PubMed/NCBI

51 

Yao Y, Hu S, Zhang C, Zhou Q, Wang H, Yang Y, Liu C and Ding H: Ginsenoside Rd attenuates cerebral ischemia/reperfusion injury by exerting an anti-pyroptotic effect via the miR-139-5p/FoxO1/Keap1/Nrf2 axis. Int Immunopharmacol. 105:1085822022. View Article : Google Scholar : PubMed/NCBI

52 

Xu J, Xie G, Yang W and Wang W, Zuo Z and Wang W: Platelet-rich plasma attenuates intervertebral disc degeneration via delivering miR-141-3p-containing exosomes. Cell Cycle. 20:1487–1499. 2021. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Ma M, Yang C, Jin S, Yang Y, Pan Y and Lin X: Eburicoic acid inhibits endothelial cell pyroptosis and retards the development of atherosclerosis through the Keap1/Nrf2/HO‑1/ROS pathway. Mol Med Rep 32: 186, 2025.
APA
Ma, M., Yang, C., Jin, S., Yang, Y., Pan, Y., & Lin, X. (2025). Eburicoic acid inhibits endothelial cell pyroptosis and retards the development of atherosclerosis through the Keap1/Nrf2/HO‑1/ROS pathway. Molecular Medicine Reports, 32, 186. https://doi.org/10.3892/mmr.2025.13551
MLA
Ma, M., Yang, C., Jin, S., Yang, Y., Pan, Y., Lin, X."Eburicoic acid inhibits endothelial cell pyroptosis and retards the development of atherosclerosis through the Keap1/Nrf2/HO‑1/ROS pathway". Molecular Medicine Reports 32.1 (2025): 186.
Chicago
Ma, M., Yang, C., Jin, S., Yang, Y., Pan, Y., Lin, X."Eburicoic acid inhibits endothelial cell pyroptosis and retards the development of atherosclerosis through the Keap1/Nrf2/HO‑1/ROS pathway". Molecular Medicine Reports 32, no. 1 (2025): 186. https://doi.org/10.3892/mmr.2025.13551
Copy and paste a formatted citation
x
Spandidos Publications style
Ma M, Yang C, Jin S, Yang Y, Pan Y and Lin X: Eburicoic acid inhibits endothelial cell pyroptosis and retards the development of atherosclerosis through the Keap1/Nrf2/HO‑1/ROS pathway. Mol Med Rep 32: 186, 2025.
APA
Ma, M., Yang, C., Jin, S., Yang, Y., Pan, Y., & Lin, X. (2025). Eburicoic acid inhibits endothelial cell pyroptosis and retards the development of atherosclerosis through the Keap1/Nrf2/HO‑1/ROS pathway. Molecular Medicine Reports, 32, 186. https://doi.org/10.3892/mmr.2025.13551
MLA
Ma, M., Yang, C., Jin, S., Yang, Y., Pan, Y., Lin, X."Eburicoic acid inhibits endothelial cell pyroptosis and retards the development of atherosclerosis through the Keap1/Nrf2/HO‑1/ROS pathway". Molecular Medicine Reports 32.1 (2025): 186.
Chicago
Ma, M., Yang, C., Jin, S., Yang, Y., Pan, Y., Lin, X."Eburicoic acid inhibits endothelial cell pyroptosis and retards the development of atherosclerosis through the Keap1/Nrf2/HO‑1/ROS pathway". Molecular Medicine Reports 32, no. 1 (2025): 186. https://doi.org/10.3892/mmr.2025.13551
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team